Success Story: EB1A Victory After RFE! How We Helped a Pakistan-Based Assistant Professor Triumph with Premium Processing
Client’s Testimonial:
“I am extremely grateful to North America Immigration Law Group for their exceptional guidance and support throughout my EB1 application process. Their expertise and attention to detail made all the difference in securing my approval. They crafted an expert and technical response to the RFE, which resulted in approval. I highly recommend their services to anyone seeking reliable and professional immigration assistance.”
On July 5th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Professor in the Field of Pediatric Medicine (Approval Notice).
General Field: Pediatric Medicine
Position at the Time of Case Filing: Assistant Professor
Country of Origin: Pakistan
State of Residence at the time of filing: Oklahoma
Approval Notice Date: July 5th, 2025
Processing Time: 3 months, 8 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group (NAILG) is pleased to announce the approval of an I-140 EB1A (Alien of Extraordinary Ability) petition for our client, a physician specializing in pediatric medicine. With a strong record of contribution to pediatric metabolic and respiratory disease management, our client’s petition was approved following a Request for Evidence (RFE) under direct premium processing, reflecting both the rigor of the case and the outstanding merit of the evidence presented. Our team carefully assembled and submitted the petition, ultimately securing approval in just over three months.
Client's Expertise and Research Focus
Our client, who holds an M.B.B.S., has emerged as a recognized expert in pediatric medicine, with a particular focus on metabolic and respiratory disease management. Among his most distinguished achievements is his investigation into adipose tissue insulin resistance (adipose-IR) in children across a range of weights and glucose tolerance statuses. Through his continued research, the client has advanced non-invasive strategies for early detection and management of type 2 diabetes and related conditions in pediatric populations, as well as provided critical insights into public health policies during respiratory disease outbreaks.
Currently appointed as an assistant professor, our client is actively contributing to research and teaching in pediatric critical care, concentrating on innovations in metabolic and respiratory illness prevention and treatment.
Demonstrated Significance in the Field
To demonstrate the client’s extraordinary ability, we documented his compliance with three EB1A regulatory criteria:
- Judging the work of others: The client has completed over 30 peer reviews for leading medical journals and conferences in pediatric and respiratory medicine. He also serves as an associate editor for a reputable scientific journal, highlighting the high level of trust placed in his expertise.
- Scholarly authorship: He has authored 5 peer-reviewed journal articles and 5scientific abstracts, with his most cited paper appearing in a top-ranked diabetes journal, placing it among the top 10% of most cited clinical medicine articles for its publication year.
Endorsements from Leading Experts
NAILG also submitted four compelling letters of recommendation from leading experts in pediatric medicine and related fields. These letters supported the petition by confirming the national and international impact of our client’s contributions. One recommender noted:
“Considering the advantages of his research, it is imperative that it remains within the nation and has full support.”
Overcoming RFE and Achieving ApprovalAlthough the petition faced an RFE, NAILG quickly and effectively addressed all USCIS concerns by furnishing additional documentary evidence and expert clarifications. The case was ultimately approved under direct premium processing, with a total turnaround from filing to approval of just over three months.
We are proud to have supported this remarkable individual through his EB1A petition process. His ongoing research in pediatric medicine promises to improve child health outcomes, refine clinical diagnostics, and inform healthcare policy in the United States. At NAILG, we remain committed to advocating for outstanding researchers whose work significantly benefits the nation.

